StockData
MTEXNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31

MANNATECH INC

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$8.74+1.62 (+22.67%)

Close on Oct 19, 2026

Market cap
$16.87M
P/E (TTM)
–
Dividend yield
–

About Mannatech

Medicinal Chemicals & Botanical Products, SIC 2833

Mannatech, Incorporated develops and sells nutritional supplements, skin care and anti-aging items, and weight-management products. The company operates in a single reporting segment within the nutritional supplement industry. Its product categories include integrative health, targeted health, weight and fitness, essentials, and Korean-inspired skin care formulations. Core offerings feature proprietary glyconutrient blends, vitamin complexes, and digestive aids. Third-party contractors manufacture all finished goods. The company sells to individual consumers, retail customers, and preferred customers who receive discounted pricing without participating in direct selling compensation.

The company distributes products primarily through independent associates in network marketing channels, along with a cross-border e-commerce model in mainland China. As of late 2025, the business had approximately 114,000 active associate and preferred customer positions across twenty-five markets. Its geographic operations encompass the Americas, Europe/the Middle East/Africa, and Asia/Pacific, alongside direct product shipments to several additional European countries. Mannatech's principal executive office is located in Flower Mound, Texas.

Summary of the business section of Mannatech's latest annual report, written by StockData.

Company profile

Company

Legal name
MANNATECH INC
Founded
1993
Headquarters
Flower Mound, TX
Address
1410 Lakeside Parkway, Suite 200 75028
Phone
(972) 471-7400
Employees
387, Dec 31, 2011
Industry
Medicinal Chemicals & Botanical Products
Incorporated in
Texas
Fiscal year ends
December 31
Auditor
BDO USA, P.C., Dallas, Texas, USA

Stock & identifiers

Ticker
MTEX
Exchange
Nasdaq
Shares outstanding
2M, Aug 5, 2026
Public float
$9.88M, Jun 30, 2025
Filer category
Non-accelerated filer<br>Smaller reporting company
Stock splits
1-for-10 reverse, Mar 29, 2012; 1-for-10 reverse, Jan 17, 2012
SEC CIK
1056358
CUSIP
563771203
ISIN
US5637712036
EIN
75-2508900

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Yasir HaiderChief Financial Officer–
James ClavijoChief Financial Officer–
Landen Granvel FredrickPresident and CEO3,975
Erin Kemmler BartaGeneral Counsel3,000
Seifrick A. JohnDirector13,746
Robert TothDirector95,920
Larry A. JobeDirector70,000
Kevin Andrew RobbinsDirector33,333
J. Stanley FredrickDirector1,611,765
Tyler RamesonDirector306,673

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2025
Landen Fredrick
$368.83K$368.83K$144.85K$61–
FY2024
Landen Fredrick
$641.07K$641.07K$90.37K$166–
FY2023
Landen Fredrick
$490.99K$490.99K$313.13K$47–

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Employees

Headcount reported in annual reports

“At December 31, 2011, we employed 387 people around the world, as set forth below:”

Corporate history

Events identified from SEC filings